QP. Quantum Phar.

TIDMQP.

RNS Number : 3513K

Quantum Pharma PLC

06 July 2017

 
 For immediate release   6 July 2017 
 

Quantum Pharma Plc

('Quantum' or the 'Company')

Result of Annual General Meeting

Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, is pleased to announce that at the Company's Annual General Meeting held earlier today, 6 July 2017, all resolutions put to the meeting were duly passed.

- Ends -

 
 For further information: 
  Quantum Pharma Plc 
 Chris Rigg, Chief Executive            Tel: +44 (0) 1207 279 404 
  Officer 
 Gerard Murray, Chief Financial          www.quantumpharmaplc.com 
  Officer 
 ir@quantumpharma.co.uk 
  N+1 Singer 
 (Nominated Advisor & Broker) 
 Sandy Fraser / Nick Owen / James     Tel: +44 (0) 20 7496 3000 
  White 
 
 
 
 Media enquiries: 
  Buchanan 
 Henry Harrison-Topham / Sophie       Tel: +44 (0) 20 7466 5000 
  Cowles 
 quantumpharma@buchanan.uk.com            www.buchanan.uk.com 
 
 

Notes to Editors

Quantum Pharma Plc is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesale and hospital markets. Quantum Pharma Plc operates through two divisions - Specials and Niche Pharmaceuticals - offering a portfolio of innovative and complementary products and services.

For further information, please visit www.quantumpharmagroup.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGRFMTTMBIMBRR

(END) Dow Jones Newswires

July 06, 2017 08:48 ET (12:48 GMT)

Quantum Phar. (LSE:QP.)
Historical Stock Chart
From Apr 2024 to May 2024

Quantum Phar. (LSE:QP.)
Historical Stock Chart
From May 2023 to May 2024